American Renal Associates (NYSE: ARA) reported Q3 EPS of $0.33, $0.28 better than the analyst estimate of $0.05. Revenue for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE